Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

When recombinant simian immunodeficiency virus (SIV) is pseudotyped with the F and HN glycoproteins from murine respiratory Sendai virus (rSIV.F/HN), it provides efficient lung cell targeting and lifelong transgene expression in the murine airways. We have shown that a single dose of rSIV.F/HN can direct stable expression of neutralising antibody against influenza in the murine airways and systemic circulation, and protects mice against two different influenza strains in lethal challenge experiments. These data suggest that rSIV.F/HN could be used as a vector for passive immunisation against influenza and other respiratory pathogens.

Original publication

DOI

10.1136/thoraxjnl-2020-214656

Type

Conference paper

Publication Date

12/2020

Volume

75

Pages

1112 - 1115

Keywords

infection control, respiratory infection, viral infection, Animals, Antibodies, Neutralizing, Gene Expression, Genetic Vectors, Hemagglutinin Glycoproteins, Influenza Virus, Immunization, Passive, Immunoglobulin G, Influenza A Virus, H1N1 Subtype, Lung, Mice, Orthomyxoviridae Infections, Sendai virus, Simian Immunodeficiency Virus, Transgenes, Weight Loss